The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hickey Benjamin since 2019.
This trader's CIK number is 1753055.
At the time of last reporting, Hickey Benjamin was the President, RayzeBio Org. of Bristol Myers Squibb Co. (stock ticker symbol BMY).
Also see all insider trading activities at Bristol Myers Squibb Co.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | MRTX | 0 | $0 | 3,687 | $217,396 | 0 | $0 |
| 2023 | MRTX | 0 | $0 | 1,566 | $66,367 | 0 | $0 |
| 2022 | MRTX | 0 | $0 | 5,839 | $473,790 | 0 | $0 |
| 2021 | MRTX | 0 | $0 | 4,447 | $866,729 | 2,369 | $270,847 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | HALO | 0 | $0 | 0 | $0 | 20,216 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | BMY | 0 | $0 | 97 | $3,686 | 10,078 | $0 |
1. Mirati Therapeutics, Inc. (MRTX)
2. Halozyme Therapeutics, Inc. (HALO)
3. Bristol Myers Squibb Co (BMY)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-16 | MRTX | Sale | 1,597 | 59.02 | 94,254 |
| 2024-01-08 | MRTX | Sale | 2,090 | 58.92 | 123,142 |
| 2023-01-17 | MRTX | Sale | 1,566 | 42.38 | 66,367 |
| 2022-12-21 | MRTX | Sale | 3,248 | 40.41 | 131,264 |
| 2022-01-18 | MRTX | Sale | 627 | 120.48 | 75,542 |
| 2022-01-07 | MRTX | Sale | 1,964 | 135.94 | 266,984 |
| 2021-03-19 | MRTX | Option Ex | 2,369 | 114.33 | 270,847 |
| 2021-03-19 | MRTX | Sale | 2,369 | 176.56 | 418,258 |
| 2021-01-07 | MRTX | Sale | 2,078 | 215.82 | 448,471 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-10-01 | HALO | Option Ex | 20,216 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-09 | BMY | Sale | 97 | 38.01 | 3,686 |
| 2025-02-01 | BMY | Option Ex | 10,078 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hickey Benjamin (President, RayzeBio Org. of Bristol Myers Squibb Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.